Delivery Order SPE2DB20D1100-SPE2DB25FD4A4
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 6, 2025, for the supply of Doxycycline Hyclate 100 mg tablets in quantities of 1,000 units, valued at $2,151.96. This is a firm fixed price delivery order with an ultimate completion date of June 9, 2025, and represents a non-competitive set-aside contract. The work will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This delivery order falls under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,413.11 to AmerisourceBergen Drug Corp for the supply of Doxycycline Mono 100 mg tablets (250-count unit) on May 30, 2025, with an ultimate completion date of June 2, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of the company's role as...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on June 18, 2025, for the supply of Doxycycline Hyclate 100 mg tablets in quantities of 1,000 units, with a contract ceiling value of $1,402.20. This is a firm fixed-price delivery order with no set-aside designation, reflecting competitive procurement through open competition. The order is scheduled for ultimate completion by June 20, 2025, and will be performed at AmerisourceBergen's corporate office...
- The Defense Logistics Agency awarded a delivery order valued at $10,374.00 to AmerisourceBergen Drug Corp for the supply of Doxycycline Hyclate 100 mg tablets (300 count) on August 21, 2025, with an ultimate completion date of August 22, 2025. This competitively awarded contract utilizes firm fixed pricing with no set-aside designation. The pharmaceutical product will be delivered to the contractor's facility in Conshohocken, Pennsylvania, where the company maintains its corporate office. This...
- The Defense Logistics Agency awarded a $20,468.22 delivery order to AmerisourceBergen Drug Corp for 60-tablet units of Doxycycline 50 mg on July 29, 2025, with an ultimate completion date of July 30, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The place of performance is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 9, 2025, for the supply of Doxycycline Hydrochloride 200 mg tablets in a 60-count package. This firm fixed-price delivery order, valued at $9,367.44, is scheduled for completion by July 10, 2025, and represents a non-set-aside competitive award. The product will be supplied from the vendor's location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters and primary...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $6,099.86 to AmerisourceBergen Drug Corp for the supply of Doxycycline 50 mg tablets (60-count packages) with an ultimate completion date of July 30, 2025. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- This is a $6,810.66 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,568,731,511 units of doxycycline 50 mg tablets. The contract has an ultimate completion date of July 9, 2025 and is not designated as a set-aside. AmerisourceBergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, designated as SPE2DX, which...
- The Defense Logistics Agency awarded a delivery order valued at $1,136.93 to AmerisourceBergen Drug Corp for the supply of Doxycycline Monohydrate 100 mg capsules in unit-dose packaging of 30 tablets. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded and completed on July 24, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the place of performance for this pharmaceutical supply arrangement. This delivery order is issued...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $2,091.90 on July 22, 2025, for the supply of Doxycycline Hyclate 100 mg tablets in unit-dose packaging (50-count). This firm fixed-price, competitively awarded contract was funded by the Defense Logistics Agency's Medical Supply Chain and is scheduled for ultimate completion by July 23, 2025. The award carries no set-aside designation, reflecting...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB25FD4A4Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,576.30 to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of Doxycycline Mono 100 mg tablets in quantities of 250 units. This is a firm fixed-price, non-set-aside contract with a completion date of July 15, 2025, and will be performed at the awardee's facility in Conshohocken, Pennsylvania. Doxycycline is a broad-spectrum tetracycline antibiotic commonly used by military and federal healthcare systems for treating bacterial infections and as a prophylactic agent. This delivery order operates under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. As a major pharmaceutical distributor, AmerisourceBergen Drug Corp fulfills critical medical procurement needs for the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems through competitively awarded contracts spanning multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.6k | 7/14/25 |